Error message

The page you requested does not exist. For your convenience, a search was performed using the query Surgical Oncology.

Page not found

Search results

  1. Obsidian Therapeutics

    of transgenes for improved safety and efficacy. JLABS @ LabCentral Oncology Platform / research tool 1 Tuesday, ...

  2. Perlara

    and BioPharma to find treatments for rare diseases. JLABS @ QB3 Oncology 1 Wednesday, January 1, 2014 ...

  3. XTuit Pharmaceuticals, Inc

    the tumor microenvironment.  Winner QuickFire Challenge Winner JLABS @ LabCentral Oncology 0 Monday, June ...

  4. Avidity NanoMedicines LLC

    diseases. JLABS @ San Diego Oncology Platform / research tool 1 Tuesday, May 28, 2013 Monday, September 23, ...

  5. Realist Pharma

    Developing oncology-focused therapeutics that treat a wide range of cancers with its main programs ... >10 highly prevalent tumor markers. JLABS @ Toronto Oncology 0 Wednesday, June 1, 2016 ...

  6. Pionyr Immunotherapeutics

    of immuno-oncology therapeutics. The company’s approach, Myeloid Tuning™, is designed to enhance the immune system’s ... JLABS @ QB3 Oncology 0 Sunday, February 1, 2015 http://www.pionyrtx.com/ ...

  7. Lin Bioscience

    of first-in-class drug candidates aiming to treat life-threatening or disabling diseases in Oncology ... and Ophthalmology indications. JLABS @ San Diego Oncology 0 Saturday, April 1, 2017 http://www.linbioscience.com/ ...

  8. Chestnut Pharmaceuticals

    cancers. The company is targeting their oncology therapeutics toward a ‘master switch’ they discovered ... metastatic while impairing the immune system through several distinct mechanisms.  JLABS @ Toronto Oncology ...

  9. Meet with… National Cancer Institute

    overseeing the Physical Sciences-Oncology Centers (PS-OC) program, a network of interdisciplinary centers ... the Tissue Engineering and Surgical Research Laboratories. Her work involved the preclinical development ...

  10. Bugs, Drugs & Beyond: Targeting the Microbiome to Transform Healthcare

    by Popular Scientist. In 2016 he won the Altemeier Prize from the Surgical Infection Society and the WH ... through Phase II programs in infectious disease, oncology, immunotherapy, and monogenetic disorders. His ...

Pages

Share